BEAM
Price
$17.62
Change
-$0.24 (-1.34%)
Updated
Aug 8 closing price
Capitalization
1.78B
92 days until earnings call
GLPG
Price
$32.56
Change
-$0.32 (-0.97%)
Updated
Aug 8 closing price
Capitalization
2.16B
87 days until earnings call
Interact to see
Advertisement

BEAM vs GLPG

Header iconBEAM vs GLPG Comparison
Open Charts BEAM vs GLPGBanner chart's image
Beam Therapeutics
Price$17.62
Change-$0.24 (-1.34%)
Volume$1.8M
Capitalization1.78B
Galapagos
Price$32.56
Change-$0.32 (-0.97%)
Volume$281.17K
Capitalization2.16B
BEAM vs GLPG Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. GLPG commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and GLPG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 10, 2025
Stock price -- (BEAM: $17.62 vs. GLPG: $32.56)
Brand notoriety: BEAM and GLPG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. GLPG: 102%
Market capitalization -- BEAM: $1.78B vs. GLPG: $2.16B
BEAM [@Biotechnology] is valued at $1.78B. GLPG’s [@Biotechnology] market capitalization is $2.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileGLPG’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • GLPG’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and GLPG are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while GLPG’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • GLPG’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than GLPG.

Price Growth

BEAM (@Biotechnology) experienced а -6.43% price change this week, while GLPG (@Biotechnology) price change was -0.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

GLPG is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLPG($2.16B) has a higher market cap than BEAM($1.78B). GLPG YTD gains are higher at: 18.400 vs. BEAM (-28.952). GLPG has higher annual earnings (EBITDA): -225.76M vs. BEAM (-399.03M). GLPG has more cash in the bank: 3.09B vs. BEAM (1.22B). GLPG has less debt than BEAM: GLPG (8.44M) vs BEAM (158M). GLPG has higher revenues than BEAM: GLPG (276M) vs BEAM (63.6M).
BEAMGLPGBEAM / GLPG
Capitalization1.78B2.16B82%
EBITDA-399.03M-225.76M177%
Gain YTD-28.95218.400-157%
P/E RatioN/A53.70-
Revenue63.6M276M23%
Total Cash1.22B3.09B39%
Total Debt158M8.44M1,871%
FUNDAMENTALS RATINGS
GLPG: Fundamental Ratings
GLPG
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMGLPG
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
54%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 13 days ago
61%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 5 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
41%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLPG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCMVX33.260.15
+0.45%
JPMorgan Mid Cap Value C
HDOGX13.820.04
+0.29%
Hennessy Total Return Investor
FMIMX38.090.11
+0.29%
FMI Common Stock Investor
ECRAX14.830.01
+0.07%
Eaton Vance RBA All Asset Strategy Fd C
EEMCX13.52-0.06
-0.44%
Columbia Emerging Markets C

GLPG and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLPG has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if GLPG jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLPG
1D Price
Change %
GLPG100%
-0.97%
VCYT - GLPG
43%
Loosely correlated
-1.12%
BEAM - GLPG
40%
Loosely correlated
-1.34%
NTLA - GLPG
39%
Loosely correlated
-5.85%
RGNX - GLPG
37%
Loosely correlated
-0.63%
AXON - GLPG
35%
Loosely correlated
-3.27%
More